Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Up 28,550.0% in December

Enzolytics, Inc. (OTCMKTS:ENZC) was the recipient of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 57,300 shares, an increase of 28,550.0% from the December 15th total of 200 shares. Based on an average daily volume of 21,887,900 shares, the days-to-cover ratio is presently 0.0 days.

Enzolytics Stock Down 9.1 %

OTCMKTS ENZC opened at $0.00 on Wednesday. Enzolytics has a one year low of $0.00 and a one year high of $0.02.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.